Stay updated with breaking news from James Cutrell. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
For more than a year antibody drugs from Regeneron and Eli Lilly have been the go-to treatments for early COVID-19, thanks to their ability to head off severe disease and keep patients out of the hospital. But laboratory testing suggests the drugs will be much less potent against omicron.
The rapidly-spreading omicron variant may soon leave U.S. doctors without two of the standard treatments they’ve used to fight COVID-19.
The omicron variant of the coronavirus makes up nearly 3% of COVID-19 cases in the US. The CDC has detected the new strain in 43 states. Latest news.
The rapidly spreading Omicron variant may soon leave U.S. doctors without two of the standard treatments they’ve used to fight COVID-19.
WASHINGTON (AP) — As strained U.S. hospitals brace for a new surge of COVID-19 cases...